Blog
LaVoie’s LHS Fifteen-Slide Presentation® for 2026: Make Your Science Stick in the AI Era Returns to BIO 2026
Donna LaVoie and Elise Simard will show biotech leaders how to build investor-ready stories that are clear, memorable, and actionable. Boston, MA, and Fort Lauderdale, FL – June 16, 2026 – LaVoie Strategic Communications…
Read MorePreparing for the IPO Window
What CEOs Need to Get Right in a Selective 2026 Market Executive Brief The life sciences IPO window is open, but selectively. In 2026, readiness is not a financing exercise…
Read MoreScience that SpeaksTM
As Creyon’s scientific platform and organizational momentum expanded, the company sought a digital presence that could clearly communicate its science, strategy, and leadership to a broad set of stakeholders. Creyon’s…
Read MoreRebranding Dyadic: How strategic storytelling helped usher in a new corporate era
In mid-2025, Dyadic International (Nasdaq: DYAI) began a transformation that would reshape both its business model and its public image. The company, with a distinguished 40-year history as a science-driven…
Read MoreAn R&D Day Before the IPO
Turning Science into Story for Investors, Analysts, and Advocates For an emerging biotech company, the period leading up to an IPO is an ideal opportunity to transform years of discoveries…
Read MoreStaying Visible, Staying Compliant
The Value of “Normal Course of Business” Communications During the IPO Quiet Period When a company enters the IPO registration phase, communications become a balancing act between transparency and restraint.…
Read More